Latest News for: ipf

Edit

Full-year financial report for the year ended 31 December 2025 (IPF - International Personal Finance plc)

Public Technologies 25 Feb 2026
IPF - International Personal Finance plc published this content on ...
Edit

Presentation (fy25 results presentation test) (IPF - International Personal Finance plc)

Public Technologies 25 Feb 2026
IPF - International Personal Finance plc published this content on February 25, ...
Edit

Presentation (ipf fy26 presentation) (IPF - International Personal Finance plc)

Public Technologies 25 Feb 2026
Mexico attracted 46,000 new customers in H2-25 (24,000 IPF Digital and 22,000 in Provident Mexico) ... IPF Digital. ... IPF Digital1 ... IPF Digital. ... IPF Digital1 ... IPF Digital broadly unchanged at 42.8% ... ‌IPF Digital.
Edit

IPF Parent Holdings boosts offer for International Personal Finance

The Business Desk 25 Feb 2026
IPF Parent Holdings has raised its recommended offer for International Personal Finance Plc to 250p per share, including a 15p special dividend ... The offer represents a premium of around 40% to IPF’s ...
Edit

Statement (ipf fy26 results statement) (IPF - International Personal Finance plc)

Public Technologies 25 Feb 2026
IPF Digital 15 ... Proposed acquisition by IPF Parent Holdings Limited ("BasePoint") ... Gerard Ryan, Chief Executive Officer at IPF commented. ... IPF Digital ... IPF Digital ... IPF Digital's RoRE moderated year on year by 3.0 ppts to 8.4% (2024.
Edit

Novel Anti-Fibrotic Drug AK3280 Cleared by FDA to Initiate Phase 2 Proof-of-Concept Clinical Trial in IPF

PR Newswire 12 Feb 2026
Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for AK3280, a novel anti-fibrotic therapy for the treatment of idiopathic pulmonary fibrosis (IPF).
Edit

Asset-Backed Securitizer Report (Form ABS-15G) (IPFS Corp)

Public Technologies 04 Feb 2026
Attached as Exhibit 99.1 hereto is the Report of Independent Certified Public Accountants dated January 27, 2026, obtained by IPFS Corporation, with respect to certain agreed-upon procedures performed by CBIZ CPAs P.C ... IPFS Corp.
Edit

GRI Bio Delivers Compelling New Phase 2a Gene Expression Data Demonstrating Improvements in Key Drivers of Fibrosis and Lung Repair in IPF (Form 8-K) (Gri Bio Inc)

Public Technologies 28 Jan 2026
) GRI Bio Delivers Compelling New Phase 2a Gene Expression Data Demonstrating Improvements in Key Drivers of Fibrosis and Lung Repair in IPF ... Gene Expression Data Show Direct Impact on the Core Biology of IPF.
Edit

Trevi Therapeutics Announces Publication of Data from the Phase 2b IPF Chronic Cough Trial of nalbuphine ER in the Journal of the American Medical Association (JAMA)

PR Newswire 22 Jan 2026
... extended-release) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC).
Edit

Director/PDMR Shareholding (IPF - International Personal Finance plc)

Public Technologies 15 Jan 2026
("IPF plc" or the "Company") ... Grant of 367,447 shares under the IPF Restricted Share Plan ... a) Grant of 213,384 shares under the IPF Restricted Share Plan ... (a) Grant of 88,911 shares under the IPF Restricted Share Plan.
Edit

Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights

Nasdaq Globe Newswire 08 Jan 2026
Pooled patients treated with TTI-101 demonstrated a 9.4% decrease from baseline in fibrosis score at week 12, compared to a 2.4% decrease for the placebo group ... .
Edit

Remedy Cell Announces Initiation of Phase 1b Clinical Trial of RC-0315 in IPF Patients

Citizen Tribune 07 Jan 2026
HAIFA, Israel, Jan.
Edit

Decoding IPFS: The Files Revolutionizing the Decentralized Future | DLU EP17

Rumble 24 Dec 2025
Click the Rumble article link to see the video ....
Edit

First IPF Biomarker Clears Initial FDA Step Toward Qualification

The Bay City Tribune 23 Dec 2025
CHICAGO, Dec ... Food and Drug Administration ....
Edit

SACMI @ IPF Bangladesh 2026 (SACMI Imola Soc Coop)

Public Technologies 18 Dec 2025
Everything's now ready for the 18th edition of IPF Bangladesh (Dhaka, 28 - 31 January 2026), where SACMI cap- and preform-making solutions will again take centre-stage ... Visit the SACMI stand at IPF Bangladesh 2026.

Article Search

tools
×
×
×
×